Clinical Trials Directory

Trials / Completed

CompletedNCT03764696

Maternal Oxygen Administration for Fetal Distress II

The Effect of Maternal Long Term High Flow Oxygen Administration During Labor on Umbilical Cord Blood Gases

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
140 (actual)
Sponsor
Navy General Hospital, Beijing · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

Supplementary oxygen is routinely administered to patients, even those with adequate oxygen saturations, in the belief that it increases oxygen delivery. However, oxygen delivery depends not just on arterial oxygen content but also on perfusion. Maternal oxygen administration has been used in an attempt to lessen fetal distress by increasing the available oxygen from the mother. However, the effect of supplemental maternal oxygen therapy on fetal acid base status has been debated for more than seven decades. The investigators found the use of 2 L/min maternal oxygen during the second stage of labor did not adversely affect either the umbilical artery pH value or the fetal heart rate (FHR) pattern distribution.

Conditions

Interventions

TypeNameDescription
DEVICEtight-fitting simple facemaskOxygen will be administered by facemask at 10 L/min oxygen. The therapy will continue until after delivery

Timeline

Start date
2021-01-01
Primary completion
2021-10-31
Completion
2021-12-31
First posted
2018-12-05
Last updated
2023-08-15

Locations

3 sites across 1 country: China

Source: ClinicalTrials.gov record NCT03764696. Inclusion in this directory is not an endorsement.